Sobre 19 señales de compra con un rendimiento T+90 consolidado. Base de rendimiento: cierre del día siguiente a la publicación.
Historial de señales
Explore the detailed record of transactions filed by Bailey Gregory. Director active across 3 companies, notably Biohaven Pharmaceutical Holding Co Ltd.. Aggregated, 26 filings have been published. Split: 21 buys · 0 sell. Total volume traded: €14.5m. Activity tracked since 19 August 2022. The latest transaction was disclosed on 31 March 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Bailey Gregory
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2.583.658 títulos@ 148,50 US$98.6% de su flujoCommon SharesSEC:0001562180-22-006953:0
25 de 26 declaraciones
About Bailey Gregory
Bailey Gregory is a declarant and Director of Serina Therapeutics, Inc., Biohaven Ltd., and Biohaven Pharmaceutical Holding Co Ltd. He has 26 filings in total, and across the 26 sampled filings, purchases amount to EUR 14,467,672 and sales to EUR 390,226,335, with activity ranging from 2022-08-22 to 2026-06-22. The modal transaction nature is Acquisition.